scholarly journals Review of the role of NICE in promoting the adoption of innovative cardiac technologies

Heart ◽  
2018 ◽  
Vol 104 (22) ◽  
pp. 1817-1822 ◽  
Author(s):  
Peter H Groves ◽  
Chris Pomfrett ◽  
Mirella Marlow
Keyword(s):  
Medical Devices ◽  
Medical Technology ◽  
Professional Community ◽  
Evidence Based ◽  
Medical Technologies ◽  
Professional Societies ◽  
Diagnostic Technologies ◽  
Improve Health

The National Institute for Health and Care Excellence (NICE) Medical Technologies Evaluation Programme (MTEP) promotes the adoption of innovative diagnostic and therapeutic technologies into National Health Service (NHS) clinical practice through the publication of guidance and briefing documents. Since the inception of the programme in 2009, there have been 7 medical technologiesguidance, 3 diagnostics guidance and 23 medtechinnovation briefing documents published that are relevant to the heart and circulation. Medical technologies guidance is published by NICE for selected single technologies if they offer plausible additional benefits to patients and the healthcare system. Diagnostic guidance is published for diagnostic technologies if they have the potential to improve health outcomes, but if their introduction may be associated with an increase in overall cost to the NHS. Medtechinnovation briefings provide evidence-based advice to those considering the implementation of new medical devices or diagnostic technologies. This review provides reference to all of the guidance and briefing medical technology documents that NICE has published that are relevant to the heart and circulation and reflect on their diverse recommendations. The interaction of MTEP with other NICE programmes is integral to its effectiveness and the means by which consistency is ensured across the different NICE programmes is described. The importance of the input of clinical experts from the cardiovascular professional community and the engagement by NICE with cardiovascular professional societies is highlighted as being fundamental to ensuring the quality of guidance outputs as well as to promoting their implementation and adoption.

The Role of Novel Bone Forming Agents in the Treatment of Osteoporosis

2020 ◽  
pp. 089719002096122
Author(s):  
Hansita B. Patel ◽  
Lynsie J. Lyerly ◽  
Cheryl K. Horlen
Keyword(s):  
Elderly Population ◽  
Cost Effective ◽  
The Elderly ◽  
Bisphosphonate Therapy ◽  
Evidence Based ◽  
First Line ◽  
Treatment Of Osteoporosis ◽  
Cost Effective Treatment

Osteoporosis is a growing epidemic that leads to significant morbidity and mortality among the elderly population due to associated fractures that lead to disabilities and reduced quality of life. Bisphosphonates are well-established as a first-line and cost-effective treatment for osteoporosis. Unfortunately, clinicians are often uncertain as to how to select treatments when bisphosphonates are ineffective as initial treatment or contraindicated. Romosozumab and abaloparatide are 2 alternative agents that have been recently FDA approved for the treatment of osteoporosis in postmenopausal women at high risk for fracture or patients who have failed or are intolerant to other osteoporosis therapies. Currently, the National Osteoporosis Foundation (NOF) has no formal recommendations in regard to these 2 novel agents. The purpose of this review is to help guide pharmacists on how to ensure appropriate utilization of these 2 novel bone-forming agents as potential alternatives to bisphosphonate therapy by providing evidence-based recommendations according to the current literature and key counseling points.

The role of the physiotherapist in the management of people with haemophilia: defining the new normal

2020 ◽  
Vol 81 (8) ◽  
pp. 1-8
Author(s):  
AJ Wells ◽  
D Stephensen
Keyword(s):  
Physical Activity ◽  
Recurrent Bleeding ◽  
Significant Shift ◽  
New Era ◽  
Assessment And Treatment ◽  
Bleeding Episodes ◽  
New Treatments ◽  
Improve Health

Physiotherapists aim to maximise quality of life and movement potential within the spheres of promotion, prevention, treatment/intervention and rehabilitation. Haemophilia care is witnessing a significant shift towards a new era of potentially life-changing treatments which offer a future of minimal or no bleeds for people with haemophilia. As such, physiotherapy intervention should be more proactive rather than reactive to treat and rehabilitate recurrent bleeding episodes. The role of the physiotherapist within the multidisciplinary team includes the differential diagnosis of musculoskeletal bleeding, supporting and encouraging higher levels of physical activity, rehabilitation to maximise physical potential and capabilities, assessment and treatment of non-bleed-related musculoskeletal issues, managing comorbidities and falls risk, and improving the longitudinal surveillance of musculoskeletal health. Encouraging and supporting people with haemophilia to become more active will improve wellbeing and improve health and health outcomes, and physical activity is becoming one of the most important outcomes for people with haemophilia. Recommendations on the best way to accurately capture these data are vital to ensure the full health benefits of new treatments for people with haemophilia are clear.

Prudent Precaution in Clinical Trials of Nanomedicines

2012 ◽  
Vol 40 (4) ◽  
pp. 831-840 ◽  
Author(s):  
Gary E. Marchant ◽  
Rachel A. Lindor
Keyword(s):  
Clinical Trials ◽  
Adverse Effects ◽  
Health Risks ◽  
Medical Technology ◽  
Health Benefits ◽  
Medical Products ◽  
Medical Technologies ◽  
Improve Health

Medical technologies, including nanomedicine products, are intended to improve health but in many cases may also create their own health risks. Medical products that create their own health risks differ from most other risk-creating technologies in that the very purpose of the medical technology is to prevent or treat health risks. This paradox of technologies intended to reduce existing risks that may have the effect of creating new risks has two conflicting implications. On one hand, we may be more tolerant of health risks from medical technologies because these products are intended to, and often (but not always) do, reduce overall health risks and improve our health. The health benefits of a medical technology may outweigh the unavoidable adverse effects of that same technology in an individual patient or in the overall treated population.

Mobile-Health (mHealth) Intervention on Chronic Kidney Diseases: A Critical Review and Its Implications (Preprint)

2020 ◽  
Author(s):  
Ira Suarilah ◽  
Chiu-Chu Lin ◽  
Chich-Hsiu Hung
Keyword(s):  
Mobile Health ◽  
Health Care Professionals ◽  
Kidney Diseases ◽  
Health Interventions ◽  
Evidence Based ◽  
Chronic Kidney Diseases ◽  
Mhealth Intervention ◽  
Center Care

BACKGROUND eElectronic health (eHealth) chronic kidney disease (CKD) information is readily available over the mobile devices and placed as mobile-health (mHealth) information resources. The field of mHealth on CKD is promising in that it can empower individuals and delay the progress of the disease. OBJECTIVE This study aims to critically review published papers on the eHealth and its implication on mHealth of CKD. METHODS The academic databases EBSCO (CINAHL and PROQUEST), MEDLINE, PubMed, and Cochrane were systematically searched. Eight studies investigated the specific role of mHealth on CKD, including the detailed contents related to the conceptual acceptance and usage of technology in daily life, user, health care professionals, and the system’s bonding, mobile eHealth, content and evaluation of mHealth on CKD. RESULTS The available evidence on mHealth of CKD is limited and the findings indicate a discrepancy of the wording concept of mHealth. Those evidences might be caused by the scarce evidence on the effectiveness of using mHealth on CKD. CONCLUSIONS The limitation on the availability of CKD’s mobile health interventions that focus on patient education, behavior change and prevention contributes to inconsistent usage. Inadequate evidence might interrupt the development of mHealth intervention for individuals with CKD. Our findings illustrate the need on the conceptualizing of mHealth on CKD, acceptance and accessed, content, and evaluation focused on evidence-based will advance the quality of mHealth services, facilitate the continuity of mHealth application, and proposed patient-center-care.

User Diversity as a Challenge for the Integration of Medical Technology into Future Smart Home Environments

2012 ◽  
pp. 553-582 ◽  
Author(s):  
Wiktoria Wilkowska ◽  
Martina Ziefle
Keyword(s):  
Medical Technology ◽  
Health Care Systems ◽  
Home Environments ◽  
Medical Technologies ◽  
Technology Generation ◽  
Age Related ◽  
Medical Sector ◽  
Care Systems ◽  
And Gender

Facing the growing aging population in many countries of the world, healthcare-related technologies become increasingly important, representing a possible solution to the soaring overstrained health care systems and dwindling number of caregivers. Though a user-centred and sensible integration of medical technology in home environments is highly challenging, especially when focusing on the group of old and frail users. Their specific needs and wants, their (dis)abilities and limitations have to be carefully considered, in order to reach full acceptance and a successful rollout of e-health applications in home environments. As the knowledge about acceptance in the medical sector is still limited, an elaborate research is needed in order to understand and respect aged persons’ specific demands. In an empirical approach, the role of age, technology generation, technical expertise, and gender are determining for the acceptance of medical technologies. As the acceptance of medical technologies might be also biased by social norms and the way aging and age-related consequences are evaluated within a society, individual ageing concepts as well as economic and educational levels were considered for the evaluation of the perceived benefits and drawbacks of medical technologies. Outcomes show the importance of understanding users’ needs and wants in order to develop user-centred medical technology concepts and to allow a successful rollout.

Practice-oriented training of students to improve their competitiveness on the hospitality industry labour market

2016 ◽  
Vol 10 (3) ◽  
pp. 3-24
Author(s):  
Ирина Гончарова ◽  
Irina Goncharova ◽  
Светлана Белова ◽  
Svetlana Belova ◽  
Ольга Байбурова ◽  
...  
Keyword(s):  
Labour Market ◽  
Hospitality Industry ◽  
Professional Community ◽  
Teaching Experience ◽  
Business English ◽  
Student Activities ◽  
International Trends ◽  
The Status

The article analyzes theoretical (organizational) and practical aspects of educational technology to enhance the quality of graduates’ education and their competitiveness on the labour market. The analysis of the status of hospitality industry and its domestic and international trends under current economic conditions has predestined the need to improve the role of educational institutions as human resources training, and the enterprises of industry - to create the conditions for the adaptation and development of the competitive capacity of specialists. The authors emphasize the advisability of introducing a public professional examination of education programs, and starting July 01, 2016 - procedures of confirmation the education quality of each university graduate. The article also defines the role of the professional community representatives in the educational programs formation, their accreditation, which indicates the need for education and business system. The possible directions of policy of educational and entrepreneurial system of hospitality industry are formulated, criteria for graduates’ competitiveness estimation by a number of components of general educational, practical and social activities are offered. The authors present teaching experience of interdisciplinary design programs using Business English in teaching university students as a development element of business resource of graduates. The indicators for student activities estimation and integrated factor of graduate’s competitiveness are offered. This allows protecting a document of high education in front of professional community.

Data Acquisition for Assessment of Medical Technology: Methods Other than Technical Trials

1986 ◽  
Vol 2 (1) ◽  
pp. 27-38 ◽  
Author(s):  
Lincoln E. Moses
Keyword(s):  
Quality Of Life ◽  
Data Acquisition ◽  
Training Program ◽  
Surgical Procedure ◽  
Educational Program ◽  
Medical Technology ◽  
Control Group ◽  
Medical Technologies ◽  
Safety Effectiveness

The term “assessment of medical technologies” does not appear to have a unique meaning that always applies to its use. It seems wise, then, to state what will be meant by the term in this chapter. “Medical technology” is regarded here as including drugs, devices, procedures, (whether preventive, diagnostic, or therapeutic) that bear more or less directly on patients. Thus, an educational program for patients might be a technology, but a training program for dietitians would not. A surgical procedure or a prosthesis would; but a scale for assessing quality of life would not. “Assessment,” as used here, refers to a complex set of activities that comprise data acquisition, analysis, and interpretation concerning properties of medical technologies. Assessment tends to be comparative, either explicitly (as to a control group) or implicitly (as looking toward “usual experience”). In any case, the goal of assessment is to increase understanding of such properties of a medical technology as its applicability, convenience, efficacy, safety, effectiveness, cost, etc.

The role of hospital payments in the adoption of new medical technologies: an international survey of current practice

2014 ◽  
Vol 10 (2) ◽  
pp. 133-159 ◽  
Author(s):  
Corinna Sorenson ◽  
Michael Drummond ◽  
Aleksandra Torbica ◽  
Giuditta Callea ◽  
Ceu Mateus
Keyword(s):  
New Technologies ◽  
Therapeutic Benefit ◽  
Payment Systems ◽  
Short Term ◽  
Medical Technologies ◽  
Adequate Funding ◽  
Related Group ◽  
Main Barrier

AbstractThis study examined the role of prospective payment systems in the adoption of new medical technologies across different countries. A literature review was conducted to provide background for the study and guide development of a survey instrument. The survey was disseminated to hospital payment systems experts in 15 jurisdictions. Fifty-one surveys were disseminated, with 34 returned. The surveys returned covered 14 of the 15 jurisdictions invited to participate. The majority (71%) of countries update the patient classification system and/or payment tariffs on an annual basis to try to account for new technologies. Use of short-term separate or supplementary payments for new technologies occurs in 79% of countries to ensure adequate funding and facilitate adoption. A minority (43%) of countries use evidence of therapeutic benefit and/or costs to determine or update payment tariffs, although it is somewhat more common in establishing short-term payments. The main barrier to using evidence is uncertain or unavailable clinical evidence. Almost three-fourths of respondents believed diagnosis-related group systems incentivize or deter technology adoption, depending on the particular circumstances. Improvements are needed, such as enhanced strategies for evidence generation and linking evidence of value to payments, national and international collaboration and training to improve existing practice, and flexible timelines for short-term payments. Importantly, additional research is needed to understand how different payment policies impact technology uptake as well as quality of care and costs.

Sign in / Sign up

Export Citation Format

Share Document